glp-1 dementia news MIND Matters | Quarterly Newsletter | Spring 2026 GLP-1 Drug Liraglutide May Protect

When the MCD enzyme is defective, it can lead to abnormal levels of malonyl CoA, which in turn can impact brain CPT1 and contribute to abnormal brain development

Int J Obes 50 , 14781485 (2026)

siRNA targeted to SLC25A39 and negative siRNA were supplied by General Biology (Chuzhou, China)

It's not a diagnostic tool for other skin conditions

Here, we present a novel mechanism by which TNBC cells of the MSL/CL subtype activate an OS response through direct induction of the NRF2 pathway by Cyss uptake, and we propose NRF2 and its direct transcriptional target OSGIN1 as interesting targets for personalized cancer treatment

Bhanote, M., Hicks, D.G., Pathology Case Reports: Pathology Case Reports, Elsevier Health Sciences